MedTrace Logo

Instrument Precision Study for Validation of Philips Dx

NCT02699970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2019-11-01

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate precision of the Philips Dx system.

Conditions

  • Pathology

Sponsors & Collaborators

  • Philips Digital & Computational Pathology

    lead INDUSTRY

Principal Investigators

  • Mischa Nelis · Philips DPS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-09-30
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699970 on ClinicalTrials.gov